Heme oxygenase (HO/HMOX1) is a cytoprotective enzyme that operates as a key rate-limiting enzyme in the process of degradation of the iron-containing molecule, heme, yielding the following by-products: CO, iron, and biliverdin (Rochette et al., 2018
There were faster granulation tissue formation, re-epithelialization, dermal remodeling, and collagen deposition through extracellular signalregulated kinases (ERK)1/2 signaling pathway as well as its downstream targets, including c-Fos, c-Jun, and egr-1
Standard Contraindications Apply All GLP-1 contraindications remain in effect: personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, pregnancy, and known hypersensitivity
Antioxidant Defense : It neutralizes free radicals, which can cause oxidative stress and damage to cells